Mersana Therapeutics (MRSN)
(Delayed Data from NSDQ)
$1.45 USD
-0.02 (-1.03%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $1.44 -0.01 (-0.35%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: BMO |
6/2024 | $-0.18 | 0.00% |
Earnings Summary
For their last quarter, Mersana Therapeutics (MRSN) reported earnings of -$0.16 per share, beating the Zacks Consensus Estimate of $-0.18 per share. This reflects a positive earnings surprise of 11.11%. Look out for MRSN's next earnings release on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.18 per share, reflecting a year-over-year increase of 61.7%.
Earnings History
Price & Consensus
Zacks News for MRSN
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Tops Revenue Estimates
MRSN: What are Zacks experts saying now?
Zacks Private Portfolio Services